About: Marine polysaccharides: therapeutic efficacy and biomedical applications

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Marine polysaccharides: therapeutic efficacy and biomedical applications Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Marine polysaccharides: therapeutic efficacy and biomedical applications
Creator	Kim, Tae Lee, Kyung Jeong, • Kim, Hyeongmin Lee, Jaehwi Lee, Young-Eun Park, Taejun Seo, Changwon Seong-Chul, • Yoo, Seung-Yup
source	Medline; PMC
abstract	The ocean contains numerous marine organisms, including algae, animals, and plants, from which diverse marine polysaccharides with useful physicochemical and biological properties can be extracted. In particular, fucoidan, carrageenan, alginate, and chitosan have been extensively investigated in pharmaceutical and biomedical fields owing to their desirable characteristics, such as biocompatibility, biodegradability, and bioactivity. Various therapeutic efficacies of marine polysaccharides have been elucidated, including the inhibition of cancer, inflammation, and viral infection. The therapeutic activities of these polysaccharides have been demonstrated in various settings, from in vitro laboratory-scale experiments to clinical trials. In addition, marine polysaccharides have been exploited for tissue engineering, the immobilization of biomolecules, and stent coating. Their ability to detect and respond to external stimuli, such as pH, temperature, and electric fields, has enabled their use in the design of novel drug delivery systems. Thus, along with the promising characteristics of marine polysaccharides, this review will comprehensively detail their various therapeutic, biomedical, and miscellaneous applications.
has issue date	2017-09-16(xsd:dateTime)
bibo:doi	10.1007/s12272-017-0958-2
bibo:pmid	28918561
has license	no-cc
sha1sum (hex)	685c2d5cece76270f787b911dd889bd82619147e
schema:url	https://doi.org/10.1007/s12272-017-0958-2
resource representing a document's title	Marine polysaccharides: therapeutic efficacy and biomedical applications
has PubMed Central identifier	PMC7090684
has PubMed identifier	28918561
schema:publication	Arch Pharm Res
resource representing a document's body	covid:685c2d5cece76270f787b911dd889bd82619147e#body_text
is schema:about of	named entity 'fucoidan' named entity 'clinical trials' named entity 'therapeutic' named entity 'exploited' named entity 'biomolecules' named entity 'Marine' named entity 'polysaccharides' named entity 'ALGAE' named entity 'BIOMEDICAL' named entity 'COATING' named entity 'ORGANISMS' named entity 'NOVEL' named entity 'POLYSACCHARIDES' named entity 'SCALE' named entity 'STIMULI' named entity 'THERAPEUTIC EFFICACY' named entity 'CLINICAL TRIALS' named entity 'PHYSICOCHEMICAL' named entity 'DEMONSTRATED' named entity 'IMMOBILIZATION' named entity 'BIOACTIVITY' named entity 'RESPOND TO' named entity 'INCLUDING' named entity 'PLANTS' named entity 'DIVERSE' named entity 'THERAPEUTIC' named entity 'IN VITRO' named entity 'BIOMOLECULES' named entity 'VIRAL INFECTION' named entity 'ELECTRIC FIELDS' named entity 'APPLICATIONS' named entity 'BIOCOMPATIBILITY' named entity 'POLYSACCHARIDES' named entity 'BIOMEDICAL' named entity 'MARINE' named entity 'CHARACTERISTICS' named entity 'LABORATORY' named entity 'TO DETECT' named entity 'BIODEGRADABILITY' named entity 'INFLAMMATION' named entity 'DESIGN' named entity 'CARRAGEENAN' named entity 'CONTAINS' named entity 'THEIR' named entity 'BIOLOGICAL PROPERTIES' named entity 'ALGINATE' named entity 'PHARMACEUTICAL' named entity 'EXTRACTED' named entity 'EXTERNAL' named entity 'CANCER' named entity 'MISCELLANEOUS' named entity 'THESE' named entity 'TEMPERATURE' named entity 'VARIOUS' named entity 'DRUG DELIVERY SYSTEMS' named entity 'ADDITION' named entity 'MARINE' named entity 'STENT' named entity 'SETTINGS' named entity 'CHITOSAN' named entity 'INHIBITION' named entity 'REVIEW' named entity 'INVESTIGATED' named entity 'NUMEROUS' named entity 'PARTICULAR' named entity 'USE' named entity 'OCEAN' named entity 'HAVE' named entity 'ENABLED' named entity 'APPLICATIONS' named entity 'EXPERIMENTS' named entity 'FUCOIDAN'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software